your shortcut to pharmaceutical decision-makers
Get a Verified Pharmaceutical Email List in Seconds
Reach VPs of Regulatory Affairs, Clinical Operations heads, Medical Affairs leaders, and Commercial directors across drug developers, generics makers, specialty pharma, and CROs and CDMOs. Access 852M+ verified contacts, only pay for what's verified.
Priya Raghavan
VP Regulatory Affairs · Pfizer
Marcus Chen
Head of Clinical Operations · Moderna
Sofia Okeke
VP Medical Affairs · Amgen
Daniel Vogel
Director Market Access · Eli Lilly
Trusted by 25,000+ businesses worldwide
Why prospect Pharmaceutical
Pharma buys long, buys by committee, and buys to move a drug to market
US prescription drug spending runs past $450B a year, and bringing one molecule from pipeline to launch can take a decade and put 7 or more stakeholders on a single purchase. VPs of Regulatory Affairs, Clinical Operations heads, Medical Affairs leaders, and Commercial directors buy trial software, lab and analytical instruments, CRO and CDMO services, pharmacovigilance tools, and market-access data to win FDA approval and protect a launch window. Saleshandy gives you a verified pharmaceutical email list of the decision-makers behind those buying committees, in real time.
$450B+
US prescription drug spend per year
$145B
US pharma manufacturing revenue, 2025
~50
novel FDA drug approvals per year
7-9
stakeholders per pipeline purchase
Decision-makers to target
Buying signals to filter on
650K+
Pharmaceutical contacts
75+
Search filters
30+
Data fields per contact
98%
Avg. verification rate
What you get
What's inside your pharmaceutical email list
Every contact in your pharmaceutical email list ships with verified emails, direct dials, and 30+ data fields, mapped to sub-vertical where relevant, verified across 9 trusted sources.
| Name | Title | Company | Sub-vertical | Headcount | Revenue | Funding | ||
|---|---|---|---|---|---|---|---|---|
| Priya Raghavan | VP of Regulatory Affairs | Pfizer | Large Pharma | 88,000 | $58.5B | Public | p.raghavan@pfizer.com | |
| Helena Kruger | Director of Regulatory Affairs | Eli Lilly | Large Pharma | 43,000 | $45.0B | Public | h.kruger@lilly.com | |
| Arjun Bhatt | Head of Regulatory Strategy | Vertex Pharmaceuticals | Specialty Pharma | 5,500 | $11.0B | Public | a.bhatt@vrtx.com | |
| Carmen Morales | VP of Regulatory Affairs | Gilead Sciences | Biotech | 18,000 | $27.1B | Public | c.morales@gilead.com | |
| Theo Nwosu | Director of Regulatory Affairs | Regeneron | Biotech | 12,000 | $13.1B | Public | t.nwosu@regeneron.com |
How it works
Get verified pharmaceutical contacts in three simple steps
Sign up for free
Create your account and get up to 50 free credits. No credit card required.
Find your exact audience
Type what you need and Sage, our AI, translates it into a precise search. Or layer 75+ filters yourself: pharmaceutical sub-vertical, headcount, revenue, hiring signals, tech stack, and more.
“Find heads of clinical operations and directors of clinical data management at US biotechs with $250M+ revenue”
Get verified contacts
Verified emails, direct dials, and 30+ data fields per pharmaceutical decision-maker, checked across 9 providers in real time. Only pay for verified results.
Reach the right pharmaceutical companies & decision-makers
Build your pharmaceutical email list from a database of 42M companies and 852M verified contacts. Filter by sub-vertical, job role, department, location, buying signals, and more.
Find VPs and directors of Regulatory Affairs at US drug developers preparing an NDA or BLA filing
Filters used
Priya Raghavan
VP of Regulatory Affairs · Pfizer
Helena Kruger
Director of Regulatory Affairs · Eli Lilly
Arjun Bhatt
Head of Regulatory Strategy · Vertex Pharmaceuticals
Carmen Morales
VP of Regulatory Affairs · Gilead Sciences
Theo Nwosu
Director of Regulatory Affairs · Regeneron
The honest pitch
Most pharmaceutical lists go stale fast. We verify every contact as you search.
Pipelines reorganize, leaders move between programs, and titles shift after every approval, licensing deal, or acquisition. We verify every contact as you search, so you don't reach outdated records.
No credit card · 7-day free trial · Cancel anytime
From list to reply
Building the pharmaceutical email list is the easy part
Verified data gets you to the right inbox. Getting a reply from a VP of Regulatory Affairs, Clinical Operations head, or Medical Affairs leader, people who run programs, not inboxes, takes a little more. Three things move the needle.
Get Up to 50 Pharmaceutical Emails Free- PRVerified
Priya Raghavan
VP Regulatory Affairs · Pfizer
- MCVerified
Marcus Chen
Head of Clinical Operations · Moderna
- SOVerified
Sofia Okeke
VP Medical Affairs · Amgen
- DVVerified
Daniel Vogel
Director Market Access · Eli Lilly
↓ three things that actually move the needle
- 01
Time it around key events
A cold email sent at a random time is easy to ignore. But if you reach out when a company posts a Phase 3 readout, files an NDA, announces a plant expansion, or closes a licensing deal, your message lands with context. These moments reshape budgets and timelines fast. Use buying signals to contact prospects right after something important changes, while the team is still building its plan.
- 02
Start with their priorities
Regulatory, clinical, and commercial leaders can spot a generic email instantly. Reference their pipeline stage, their lead indication, their therapeutic area, or a recent approval to show you did the homework. Focus on outcomes like protecting a launch window or speeding a submission, not a product demo. One specific sentence is more effective than a long pitch.
- 03
Use more than email
Don't rely on email alone. With verified direct dials and LinkedIn profiles, you can reach the same person across channels. A VP of Regulatory Affairs who skips your email may still answer a call or accept a LinkedIn request between trial milestones. Reaching out across email, phone, and LinkedIn together consistently improves response rates over any single channel.
More industry lists
Selling into a different industry?
Customer reviews
Teams winning Pharmaceutical accounts with Saleshandy
Real feedback from teams using Saleshandy to grow their pipeline.
92%
email verification rate
“We pulled 3,000 contacts for a campaign — 92% of emails verified on first try. The data accuracy is unreal. Nothing else we've used comes close.”
Thomas Foley
Founder · HighTouch
23%
higher accuracy vs Apollo
“We ran a side-by-side test vs Apollo and ZoomInfo. Saleshandy Lead Finder had 23% higher email accuracy and cost us a fraction of the price. Switched our entire team over.”
Gareth Hayter
Founder & CEO · Slyce Software Ltd
3%
bounce rate (down from 12%)
“Lead Finder gives me real-time verified emails — not stale data from 6 months ago. My team's bounce rate dropped from 12% to under 3%.”
Julia M.
Director of Sales · Small Business
1,713+ verified reviews across platforms
Pharmaceutical email list FAQs
Reveal Up to 50 Free Pharmaceutical Contacts
No credit card · 7-day free trial